GCTK GlucoTrack Inc.: Long-Term Debt to Capital Coefficient

Corporate emblem and logo of GlucoTrack (GCTK)

This daily price chart for GlucoTrack, Inc. (GCTK) reflects the price action of an asset whose operating model relies on outsourcing electronics assembly through vetted contractors, which fixes the indicator at 0.00. GlucoTrack, Inc. (GCTK) develops revolutionary painless glucose sensors, eliminating the need for patient finger-pricks. However, trade wars and chip export restrictions from Asia are creating certain supply chain complexities.

GCTK - glucotrack.com Long-Term Debt to Equity over the range 04/28/2023 - 10/29/2026
Brand item of GlucoTrack Inc.

This indicator compares liabilities with a maturity of more than one year against total equity. The ratio determines the extent of the company's reliance on long-term debt financing when forming assets. For GlucoTrack, Inc. (GCTK), which develops high-precision non-invasive glucose monitoring systems, the balance of borrowings is critical when scaling innovations. By analyzing the long-term debt-to-equity ratio, an investor assesses the financial stability of the business. The trend in this long-term debt-to-equity ratio reveals default risks or the underutilization of leverage.

Key competitors

Long-Term Loans to Capital Ratio DexCom Inc|Penumbra Corp (PEN) - Long-Term Debt to Capital|Long-Term Debt to Capital Coefficient Novanta Photonics (NOVT)|HAE: Long-Term Debt to Capital|inspiresleep.com - Long-Term Liabilities to Capital|Long-Term Debt to Equity PROCEPT BioRobotics Corporation (PRCT)|CNMD - Long-Term Debt to Capital Coefficient|PLSE: Long-Term Debt to Capital|INMD (InMode MD) - Long-Term Debt to Capital|Long-Term Debt to Equity Picard Medical Inc PMI|Long-Term Liabilities to Equity surmodics.com|Eversense - Long-Term Debt to Capital|Long-Term Liabilities to Capital NeuroPace Inc NPCE|Long-Term Debt to Equity Ratio TCMD (Tactile Medical)|SNWV - Long-Term Debt to Capital|Long-Term Debt to Equity Ratio Outset Medical, Inc. OM|ELMD - Long-Term Loans to Capital Ratio|LENSAR - Long-Term Debt to Capital|AVITA Medical Inc. (RCEL) - Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Capital PROF|Long-Term Debt to Equity Ratio Baird Medical Corp (BDMD)|EDAP TMS S.A. (EDAP) - Long-Term Debt to Equity Ratio|Long-Term Debt to Capital Coefficient APYX (apyxmedical.com)|IceCure Medical - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio Pulmonx Corp LUNG|TELA (TELA Bio Corp) - Long-Term Debt to Capital|CTSO - Long-Term Liabilities to Capital|Long-Term Debt to Capital Sensus Healthcare, Inc.|zynex.com (ZYXI) - Long-Term Debt to Capital Ratio|ECOR: Long-Term Debt to Capital|Ratio of Long-Term Indebtedness to Capital Vicarious Surgical Corp|Long-Term Debt to Capital IINN (Inspira Technologies Oxy)|Long-Term Debt to Equity Ratio SeaStar Medical Holding Corp. (ICU)|Long-Term Debt to Capital IRIX (IRIDEX)|Intelligent Bio Solutions Inc - Long-Term Debt to Capital|XAIR - Long-Term Debt to Equity|Profusa Inc. (PFSA) - Long-Term Debt to Equity|Long-Term Debt to Equity Ratio strataskinsciences.com SSKN|NanoVibronix Inc. (NAOV) - Long-Term Debt to Capital Coefficient|Long-Term Debt to Capital VERO (Venus Concept Inc.)|Long-Term Liabilities to Capital NUWE|AEMD: Long-Term Debt to Equity|Long-Term Indebtedness to Equity asensus.com ASXC|Long-Term Debt to Equity Ratio AVGR (Avinger, Inc)|Long-Term Debt to Capital BioSig Technologies Inc. BSGM|Long-Term Debt to Capital CUTR (Cutera, Inc.)|KNW: Ratio of Long-Term Indebtedness to Capital|Long-Term Debt to Equity Inari Medical (NARI)|NVRO (Nevro Corp) - Long-Term Liabilities to Equity|Long-Term Debt to Equity RSLS|Long-Term Debt to Equity Ratio Silk Road Medical Inc